Synageva Prices 2.15M Share Public Offering at $47.53/Share
Synageva BioPharma (NASDAQ: GEVA) today announced the pricing of its previously announced
underwritten public offering of common stock consisting of 2,150,000
shares at $47.53 per share. In connection with this offering, Synageva
granted to the underwriters a 30-day option to purchase 322,500
additional shares of common stock.
Morgan Stanley and J.P. Morgan are acting as joint book-running managers
in the offering, and Cowen and Company, Canaccord Genuity Inc., and
Leerink Swann LLC are acting as co-managers in the offering.
The securities described above are being offered by Synageva pursuant to
a Form S-3 shelf registration